<p>Research suggests defatting livers during machine perfusion can improve transplant outcomes, but it’s still being studied. It seems likely that drugs like forskolin and L-carnitine help reduce liver fat, with early studies showing promise. The evidence leans toward machine perfusion, especially normothermic, being a key method for defatting, though more research is needed.</p>

Research suggests defatting livers during machine perfusion can improve transplant outcomes, but it’s still being studied. It seems likely that drugs like forskolin and L-carnitine help reduce liver fat, with early studies showing promise. The evidence leans toward machine perfusion, especially normothermic, being a key method for defatting, though more research is needed.

Defatting liver during Machine Perfusion

Step into the forefront of abdominal transplant surgery — where innovation meets ongoing complexity. Machine perfusion and normothermic regional perfusion (NRP) are reshaping organ preservation and donor utilization, with growing evidence that these technologies improve graft assessment and early outcomes. Yet reviews continue to highlight key challenges — ischemia–reperfusion injury, biliary complications in DCD grafts, and the logistical demands of perfusion platforms. Despite these hurdles, transplantation is shifting from an urgent, unpredictable field toward a planned, daytime specialty. The next horizon, underscored by recent expert reviews, is true organ banking — bringing us closer to on-demand, schedulable transplantation.

Share Defatting liver during Machine Perfusion

Sign up to save your podcasts

Defatting liver during Machine Perfusion

Defatting liver during Machine Perfusion